Correlation Between Structure Therapeutics and Phathom Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Phathom Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Phathom Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Phathom Pharmaceuticals, you can compare the effects of market volatilities on Structure Therapeutics and Phathom Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Phathom Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Phathom Pharmaceuticals.
Diversification Opportunities for Structure Therapeutics and Phathom Pharmaceuticals
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Structure and Phathom is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Phathom Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phathom Pharmaceuticals and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Phathom Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phathom Pharmaceuticals has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Phathom Pharmaceuticals go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Phathom Pharmaceuticals
Given the investment horizon of 90 days Structure Therapeutics American is expected to generate 0.69 times more return on investment than Phathom Pharmaceuticals. However, Structure Therapeutics American is 1.45 times less risky than Phathom Pharmaceuticals. It trades about -0.13 of its potential returns per unit of risk. Phathom Pharmaceuticals is currently generating about -0.22 per unit of risk. If you would invest 3,870 in Structure Therapeutics American on September 10, 2024 and sell it today you would lose (535.00) from holding Structure Therapeutics American or give up 13.82% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Structure Therapeutics America vs. Phathom Pharmaceuticals
Performance |
Timeline |
Structure Therapeutics |
Phathom Pharmaceuticals |
Structure Therapeutics and Phathom Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Structure Therapeutics and Phathom Pharmaceuticals
The main advantage of trading using opposite Structure Therapeutics and Phathom Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Phathom Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phathom Pharmaceuticals will offset losses from the drop in Phathom Pharmaceuticals' long position.Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |